Study of Selected BRCA1, BRCA2, and PIK3CA Mutations in Benign and Malignant Lesions of Anogenital Mammary-Like Glands
Language English Country United States Media print
Document type Journal Article
- MeSH
- Paget Disease, Extramammary genetics pathology MeSH
- Class I Phosphatidylinositol 3-Kinases genetics MeSH
- Risk Assessment MeSH
- Immunohistochemistry MeSH
- Biopsy, Needle MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Mammary Glands, Human pathology MeSH
- Mutation MeSH
- Anus Neoplasms genetics pathology MeSH
- Vulvar Neoplasms genetics pathology MeSH
- Prognosis MeSH
- BRCA1 Protein genetics MeSH
- BRCA2 Protein genetics MeSH
- Gene Expression Regulation, Neoplastic MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- BRCA1 protein, human MeSH Browser
- BRCA2 protein, human MeSH Browser
- Class I Phosphatidylinositol 3-Kinases MeSH
- PIK3CA protein, human MeSH Browser
- BRCA1 Protein MeSH
- BRCA2 Protein MeSH
Anogenital mammary-like glands (AGMLGs) are nowadays considered a normal component of the anogenital area. Lesions involving AGMLGs are histopathologically very similar to their mammary counterparts, but the information on molecular biological mechanisms in these vulvar/perianal tumors is scarce. Mutations in the PI3K-AKT cascade have been found in hidradenoma papilliferum. The authors studied selected BRCA1, BRCA2, and PIK3CA mutations in series of benign and malignant neoplasms thought to be associated with AGMLGs, including 9 cases of primary extramammary Paget disease, 3 different cases of mammary-type carcinoma (adenoid cystic like, tubulolobular, and invasive ductal like), and 5 cases of hidradenoma papilliferum. No BRCA mutation was detected, whereas 3 neoplasms yielded PIK3CA mutation, including extramammary Paget disease, mammary-type invasive ductal carcinoma, and tubulolobular carcinoma. Our study expands the spectrum of lesions of AGMLGs harboring mutations in genes encoding the PI3K-AKT cascade. Further studies of the whole BRCA1 and BRCA2 genes using a larger cohort are needed to clarify their role in the pathogenesis of AGMLG lesions.
References provided by Crossref.org